Virbac strengthens its position in Chilean animal health market
The company aims to bring innovative products and solutions to the local market for the cold and warm-water fish segments.
Virbac acquired 15% of the shares of the Centrovet group, increasing its stake to 66% while retaining the possibility of subsequently acquiring all or part of the remaining shares. Virbac acquired a 51% of the shares of Centrovet group in 2012.
Sébastien Huron, chief executive officer of Virbac group, said that “with this acquisition, we are consolidating our position in this promising market and strategic aquaculture segment for our group, Chile being the world's second-largest producer of salmon. Centrovet, thanks to its industrial footprint and R&D infrastructures, gives us a real competitive advantage in the Chilean aquaculture industry. With a highly engaged team, we have the ambition to further bring innovative products and solutions to the local market and search for additional synergies on the R&D and manufacturing sides between the cold and warm-water fish segments.”